GENinCode (LON:GENI) Shares Up 8.7% – Time to Buy?

GENinCode Plc (LON:GENI) shares were up 8.7% on Tuesday . The stock traded as high as GBX 1.14 and last traded at GBX 1.14. Approximately 10,131,498 shares were traded during mid-day trading, an increase of 77% from the average daily volume of 5,733,112 shares. The stock had previously closed at GBX 1.04.

GENinCode Price Performance

The firm has a 50-day simple moving average of GBX 1.13 and a 200-day simple moving average of GBX 1.71. The firm has a market cap of £8.23 million, a P/E ratio of -0.48 and a beta of 0.61. The company has a current ratio of 2.80, a quick ratio of 15.89 and a debt-to-equity ratio of 7.17.

GENinCode Company Profile

GENinCode Plc is a UK based company specialising in genetic risk assessment of cardiovascular disease. Cardiovascular disease is the leading cause of death and disability worldwide.

GENinCode operates business units in the UK, in the United States through GENinCode U.S. Inc and in Europe through GENinCode S.L.U.

GENinCode predictive technology provides patients and physicians with globally leading preventative care and treatment strategies. GENinCode CE marked invitro-diagnostic molecular tests combine clinical algorithms and bioinformatics to provide advanced patient risk assessment to predict disease onset.